N,N,N-Trimethyl chitosan as a permeation enhancer for inhalation drug delivery: interaction with a model pulmonary surfactant

Jana Szabová,Filip Mravec,Mostafa Mokhtari,Rémi Le Borgne,Michal Kalina,Jean-François Berret

DOI: https://doi.org/10.1016/j.ijbiomac.2023.124235

2023-04-01

Abstract:N,N,N-Trimethyl chitosan (TMC), a biocompatible and biodegradable derivative of chitosan, is currently used as a permeation enhancer to increase the translocation of drugs to the bloodstream in the lungs. This article discusses the effect of TMC on a mimetic pulmonary surfactant, Curosurf, a low-viscosity lipid formulation administered to preterm infants with acute respiratory distress syndrome. Curosurf exhibits a strong interaction with TMC, resulting in the formation of aggregates at electrostatic charge stoichiometry. At nanoscale, Curosurf undergoes a profound reorganization of its lipid vesicles in terms of size and lamellarity. The initial micron-sized vesicles (average size 4.8 microns) give way to a froth-like network of unilamellar vesicles about 300 nm in size. Under such conditions, neutralization of the cationic charges by pulmonary surfactant may inhibit TMC permeation enhancer capacity, especially as electrostatic charge complexation is found at low TMC content. The permeation properties of pulmonary surfactant-neutralized TMC should then be evaluated for its applicability as a permeation enhancer for inhalation in the alveolar region.

Quantitative Methods,Soft Condensed Matter

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to evaluate the role of N,N,N - trimethyl chitosan (TMC) as a penetration enhancer in inhaled drug delivery, especially its interaction with pulmonary surfactants (such as Curosurf®). Specifically, the research focuses on the following points: 1. **Interaction between TMC and pulmonary surfactant**: - Research on the charge complexation between TMC and Curosurf®, especially the formation of complexes when the charge ratio reaches a certain value. - Explore the impact of this interaction on the structure of Curosurf®, especially the changes in the size of lipid vesicles and the lamellar structure. 2. **Structural changes of Curosurf®**: - Describe the process of Curosurf® changing from micron - sized multilamellar vesicles to nanometer - sized unilamellar vesicles after interacting with TMC. - Analyze the impact of this structural change on the penetration - enhancing ability of TMC. 3. **Penetration - enhancing ability of TMC**: - Evaluate whether TMC after neutralization by Curosurf® still has the potential as a penetration enhancer in inhaled drug delivery systems. - Discuss the potential inhibitory effect of charge complexation on the penetration - enhancing effect of TMC, especially at low TMC content. Through these studies, the paper aims to provide a theoretical basis for the application of TMC in pulmonary drug delivery and explore how to optimize its use in clinical treatment.

N,N,N-Trimethyl chitosan as a permeation enhancer for inhalation drug delivery: interaction with a model pulmonary surfactant

Computational Investigations of the Interaction Between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant.

Study Interactions Between Inhaled Nanoparticles and Pulmonary Surfactant Using Molecular Dynamics Simulations

The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants

Fine-tuning the cytotoxicity profile of N,N,N-trimethyl chitosan through trimethylation, molecular weight, and polyelectrolyte complex nanoparticles

Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.

Biophysicochemical interaction of a clinical pulmonary surfactant with nano-alumina

A pseudo‐surfactant chemical permeation enhancer to treat otitis media via sustained transtympanic delivery of antibiotics

Novel biomimetic surfactant: synthesis and micellar characteristics.

Lipopolymers and lipids from lung surfactants in association with N-acetyl-l-cysteine: Characterization and cytotoxicity

Effect of the Surface Charge Density of Nanoparticles on Their Translocation Across Pulmonary Surfactant Monolayer: a Molecular Dynamics Simulation

Pulmonary surfactant inhibition of nanoparticle uptake by alveolar epithelial cells

Evaluating Novel SP-B and SP-C Synthetic Analogues for Pulmonary Surfactant Efficacy

Vesicle-to-micelle transition in a double chain quaternary ammonium surfactant system: Interfacial behavior and molecular insights

Tailoring N, N, N‐trimethyl chitosan nanospheres as an efficient drug carrier to overcome endothelial barrier

Constrained drop surfactometry for studying adsorbed pulmonary surfactant at physiologically relevant high concentrations

Surfactant-modified fatty acid composition of Citrobacter sp. SA01 and its effect on phenanthrene transmembrane transport

Preparation and Evaluation of Mucus-Penetrating Inhalable Microparticles of Tiotropium Bromide Containing Sodium Glycocholate

Poly(amidoamine) Dendrimer As a Respiratory Nanocarrier: Insights from Experiments and Molecular Dynamics Simulations

Functionalisation of chitosan with methacryloyl and crotonoyl groups as a strategy to enhance its mucoadhesive properties

Polyhydroxyalkanoate Nanoparticles for Pulmonary Drug Delivery: Interaction with Lung Surfactant